4-SUBSTITUTED PYRROLO[2,3-B]PYRIDINE AS ERBB MODULATORS USEFUL FOR TREATING CANCER
申请人:Lead Discovery Center GmbH
公开号:EP3613738A1
公开(公告)日:2020-02-26
The present invention relates to certain 4-substituted 1H-pyrrolo[2,3-b]pyridine compounds of the formula (I) and pharmaceutically acceptable salts thereof. These compounds is useful in the treatment or prevention of a disease or medical condition mediated through certain mutated forms of ErbB receptor, especially of Exon20 Her2 and EGFR mutations.
本发明涉及某些4-取代的1H-吡咯并[2,3-b]吡啶化合物(I)及其药学上可接受的盐。这些化合物在治疗或预防通过某些突变形式的ErbB受体介导的疾病或医疗状况方面具有用途,特别是Exon20 Her2和EGFR突变。